Table 5. Clinical findings, metastases and AChR-Ab among patients with or without MG.
| Clinical finding | All (n=64), % (n/N) | Thymoma | P | |
|---|---|---|---|---|
| With MG (n=18), % (n/N) | Without MG (n=46), % (n/N) | |||
| Diplopia | <0.001 | |||
| Present | 25 (16/64) | 83.3 (15/18) | 2.2 (1/46) | |
| Absent | 75 (48/64) | 16.7 (3/18) | 97.8 (45/46) | |
| Appendicular weakness | <0.001 | |||
| Present | 26.6 (17/64) | 72.2 (13/18) | 8.7 (4/46) | |
| Absent | 73.4 (47/64) | 27.8 (5/18) | 91.3 (42/46) | |
| Ptosis | <0.001 | |||
| Present | 20.3 (13/64) | 72.2 (13/18) | 0 (0/46) | |
| Absent | 79.7 (51/64) | 27.8 (5/18) | 100.0 (46/46) | |
| Dysphagia | <0.001 | |||
| Present | 20.3 (13/64) | 61.1 (11/18) | 4.3 (2/46) | |
| Absent | 79.7 (51/64) | 38.9 (7/18) | 95.7 (44/46) | |
| Speech impairment | <0.001 | |||
| Present | 18.7 (12/64) | 50.0 (9/18) | 6.5 (3/46) | |
| Absent | 81.2 (52/64) | 50.0 (9/18) | 93.5 (43/46) | |
| Dyspnea | 0.528 | |||
| Present | 56.2 (36/64) | 50.0 (9/18) | 58.7 (27/46) | |
| Absent | 43.7 (28/64) | 50.0 (9/18) | 41.3 (19/46) | |
| Cough | 0.084 | |||
| Present | 39.1 (25/64) | 22.2 (4/18) | 45.7 (21/46) | |
| Absent | 60.9 (39/64) | 77.8 (14/18) | 54.3 (25/46) | |
| Pleural effusion | 0.221 | |||
| Present | 14.1 (9/64) | 5.6 (1/18) | 17.4 (8/46) | |
| Absent | 85.9 (55/64) | 94.4 (17/18) | 82.6 (38/46) | |
| Red series aplasia | 0.837 | |||
| Present | 4.7 (3/64) | 5.6 (1/18) | 4.3 (2/46) | |
| Absent | 95.3 (61/64) | 94.4 (17/18) | 95.7 (44/46) | |
| Metastases | 0.062 | |||
| Present | 40.6 (26/64) | 33.3 (6/18) | 43.5 (20/46) | |
| Absent | 59.4 (38/64) | 66.7 (12/18) | 56.5 (26/46) | |
| AChR-Ab positive | <0.001 | |||
| Present | 21.9 (14/64) | 77.8 (14/18) | 0 (0) | |
| Absent | 4.7 (3/64) | 0 (0) | 6.5 (3/46) | |
| NA/NS | 73.4 (47/64) | 22.2 (4/18) | 93.5 (43/46) | |
NA, not applicable; NS, not specified; AChR-Ab, acetylcholine receptor antibody.